More articles from Oncology: Clinical Diagnosis: Prostate/GU

You have access
Dual phase 18F-FDG PET/CT imaging in evaluation of “radio-recurrent” prostate cancer
Athar Haroon, Ahmad Almuhaideb, John Dickson, Hashim Ahmed, Rizwan Syed, Alex Kirkham, Irfan Kayani, Mark Emberton and Jamshed Bomanji

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1901;
You have access
Early dynamic PET/CT and 18F-FDG blood flow imaging in bladder cancer detection: A novel approach
Sam Belakhlef, Clifford Church, Chirag Jani and Suresh Lakhanpal

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1909;
You have access
Whole body human biodistribution of the PSMA inhibitor [18F]DCFBC
Kenneth Gage, Jennifer Coughlin, Christopher Endres, George Sgouros, Catherine Foss, Ronnie Mease, Robert Dannals, Daniel Holt, Steve Cho and Martin Pomper

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1910;
You have access
Chemotherapy associated changes in metastatic tumor 18F-fluorocholine uptake and circulating DNA levels in hormone-refractory prostate cancer
Sandi Kwee, Min-Ae Song, Lenora Loo, Iona Cheng and Maarit Tiirikainen

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1903;
You have access
Role of C-11-Choline-PET/CT in evaluation of patients affected by prostate cancer with suspected relapse due to PSA elevation
Francesco Bertagna, Muhannad Abuhilal, Giovanni Bosio, Claudio Simeone, Pierluigi Rossini, Claudio Pizzocaro, Emanuela Orlando, Giorgio Biasiotto, Sergio Cosciani Cunico and Raffaele Giubbini

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1907;
You have access
Preliminary evaluation of 18F-NaF and 18F-FDG PET/CT in detection of metastatic disease in men with PSA relapse after treatment for localized primary prostate cancer
Hossein Jadvar, Bhushan Desai, Peter Conti, Tanya Dorff, Mitchell Gross and David Quinn

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1916;
You have access
FCH PET/CT in the assessment of recurrent prostate cancer: Correlation with PSA level
Mohsen Beheshti, Rasoul Zakavi, Silke Haim, Martin Steinmair, Peter Waldenberger, Iris Wolf, Michael Nader, Wolfgang Loidl and Werner Langsteger

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1913;
You have access
18FDG-PET/CT in the assessment of lymph node involvement in patients with invasive penile carcinoma
Isabelle Souillac, Francoise Kraeber-Bodere, Olivier Bouchot, Jérôme Rigaud, Thomas Carlier and Catherine Ansquer

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1905;
You have access
The importance of SPECT-CT in sentinel lymph node detection with prostate cancer patients
Ildikó Balogh, András Páczelt, József Varga, Károly Pócza and Zoltán Galler

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1912;
You have access
Clinical value of [F-18]-Fluorodeoxyglucose PET/CT in locally recurrent and metastatic bladder transitional cell carcinoma
Yun Jung Choi, Won Jun Kang, Arthur Cho, Hyo Jung Seo, Hyun Jeong Kim, Mijin Yun and Jong Doo Lee

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1904;

Main menu

User menu

Search

More articles from Oncology: Clinical Diagnosis: Prostate/GU

Pages